Your browser doesn't support javascript.
loading
Safety and immunogenicity of sequential administration of PCV13 followed by PPSV23 in pneumococcal vaccine-naïve adults aged ≥ 65 years: Comparison of booster effects based on intervals of 0.5 and 1.0 year.
Azuma, Momoyo; Oishi, Kazunori; Akeda, Yukihiro; Morino, Saeko; Motoki, Yumi; Hanibuchi, Masaki; Nishioka, Yasuhiko.
Afiliación
  • Azuma M; Department of Infection Control and Prevention, Tokushima University Hospital, Japan. Electronic address: azumm@tokushima-u.ac.jp.
  • Oishi K; Toyama Institute of Health, Toyama, Japan.
  • Akeda Y; Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan; Division of Infection Control and Prevention, Osaka University Hospital, Osaka University, Osaka, Japan; Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Osaka, Japan;
  • Morino S; Centre for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
  • Motoki Y; Hakuai Memorial Hospital.
  • Hanibuchi M; Department of Community Medicine for Respirology, Hematology and Metabolism Graduate School of Biomedical Sciences, Tokushima University, Japan.
  • Nishioka Y; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Vaccine ; 41(5): 1042-1049, 2023 01 27.
Article en En | MEDLINE | ID: mdl-36593171

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Streptococcus pneumoniae Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Streptococcus pneumoniae Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos